Nuvalent Stock Analysis

Nuvalent Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The book value of Nuvalent was now reported as 15.81. The company recorded a loss per share of 3.49. Nuvalent had not issued any dividends in recent years. Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Nuvalent Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people. To find out more about Nuvalent contact James Porter at 857 357 7000 or learn more at https://www.nuvalent.com.

Nuvalent Investment Alerts

Nuvalent Upcoming and Recent Events

Nuvalent Largest EPS Surprises

View All Earnings Estimates

Nuvalent Environmental, Social, and Governance (ESG) Scores

Nuvalent Stock Institutional Investors

Note, although Nuvalent's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nuvalent Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.39 B.

Nuvalent Profitablity

Management Efficiency

Nuvalent has return on total asset (ROA) of (0.1863) % which means that it has lost $0.1863 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2957) %, meaning that it created substantial loss on money invested by shareholders. Nuvalent's management efficiency ratios could be used to measure how well Nuvalent manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -0.16 this year. Return On Capital Employed is expected to rise to -0.23 this year. At this time, Nuvalent's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 559 M this year, although the value of Non Currrent Assets Other will most likely fall to about 5 M.

Technical Drivers

As of the 26th of February, Nuvalent secures the Mean Deviation of 1.86, risk adjusted performance of (0.03), and Standard Deviation of 2.47. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvalent, as well as the relationship between them. Please verify Nuvalent market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Nuvalent is priced some-what accurately, providing market reflects its recent price of 76.88 per share. Given that Nuvalent has information ratio of (0.06), we recommend you to check Nuvalent's last-minute market performance to make sure the company can sustain itself at a future point.

Nuvalent Price Movement Analysis

Nuvalent Insider Trading Activities

Nuvalent Outstanding Bonds

Nuvalent Predictive Daily Indicators

Nuvalent Corporate Filings

Nuvalent Forecast Models

Nuvalent's time-series forecasting models are one of many Nuvalent's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuvalent's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvalent prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvalent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nuvalent. By using and applying Nuvalent Stock analysis, traders can create a robust methodology for identifying Nuvalent entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nuvalent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nuvalent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Nuvalent stock analysis indicators help investors evaluate how Nuvalent stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nuvalent shares will generate the highest return on investment. By understating and applying Nuvalent stock analysis, traders can identify Nuvalent position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.